GO-Y030 is primarily researched for its potential anti-cancer properties. It has shown promise in inhibiting the growth of various cancer cells, particularly in studies focusing on colorectal cancer. The compound works by targeting specific pathways involved in cancer cell proliferation and survival, making it a candidate for future therapeutic development. Additionally, GO-Y030 has been studied for its role in reducing inflammation, which could have implications for treating inflammatory diseases. Its ability to modulate key cellular processes also makes it a subject of interest in broader biomedical research.